Shirahase; Hiroaki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shirahase; Hiroaki.The latest application filed is for "novel cyclin-dependent kinase 8 and/or 19 inhibitor".

Company Profile

0.8.7

Shirahase; Hiroaki - Kyoto JP
Shirahase; Hiroaki - Nagaokakyo JP
Shirahase, Hiroaki - Nagaokakyo-shi Kyoto JP
Shirahase, Hiroaki - Nagaokakyo-shi Kyoto

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclin-dependent kinase 8 and/or 19 inhibitor Grant 11,013,728 - Kitao , et al. May 25, 2	2021-05-25
Novel Cyclin-dependent Kinase 8 And/or 19 Inhibitor App 20210100783 - KITAO; Tatsuya ; et al.	2021-04-08
Aromatic compound and use thereof Grant 10,059,663 - Shirahase , et al. August 28, 2	2018-08-28
Novel Aromatic Compound And Use Thereof App 20160207883 - SHIRAHASE; Hiroaki ; et al.	2016-07-21
Tetrahydroisoquinoline Compound and Medicinal Use Thereof App 20100022582 - Takahashi; Kenji ; et al.	2010-01-28
Heterocyclic compound and medicinal use thereof Grant 7,557,123 - Matsui , et al. July 7, 2	2009-07-07
Indoline compound and medicinal use thereof Grant 7,429,612 - Kamiya , et al. September 30, 2	2008-09-30
Novel indoline compound and medicinal use thereof App 20060128787 - Kamiya; Shouji ; et al.	2006-06-15
Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors Grant RE38,970 - Kamiya , et al. February 7, 2	2006-02-07
Heterocyclic derivatives and medicinal use thereof Grant 6,872,732 - Matsui , et al. March 29, 2	2005-03-29
Novel heterocyclic compound and medicinal use thereof App 20040220215 - Matsui, Hiroshi ; et al.	2004-11-04
Novel heterocyclic derivatives and medicinal use thereof App 20040180924 - Matsui, Hiroshi ; et al.	2004-09-16
Novel heterocyclic compounds and salts thereof and medicinal use of the same App 20030027836 - Matsui, Hiroshi ; et al.	2003-02-06
Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors Grant 6,063,806 - Kamiya , et al. May 16, 2	2000-05-16
Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof Grant 5,990,150 - Matsui , et al. November 23, 1	1999-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.